Institutional Ownership
Moonlake Immunotherapeutics
CUSIP 61559X104CLASS A ORDMLTXQ1 2026
No Form 4 insider transactions ingested yet
Insider (Form 4) filings for Moonlake Immunotherapeutics are fetched from SEC EDGAR on a rolling basis. Check back shortly.